Match Document Document Title
7410956 Caspase inhibitor prodrugs  
The present invention relates to compounds of formula I which are prodrugs of caspase inhibitors and pharmaceutically acceptable salts thereof. This invention further relates to the release of...
7407946 Quinazoline compounds  
Quinazoline derivatives of formula (I) wherein A is 5-membered heteroaryl containing a sulphur atom and optionally containing one or more nitrogen atoms; compositions containing them, processes for...
7365096 Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)  
Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of...
7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX  
The present invention relates to derivatives of succinic and glutaric acids and analogues thereof, having the following general formula: useful as inhibitors of PHEX. These derivatives are...
7351698 Androgen receptor modulators and methods of use thereof  
Compounds of structural formula (I) as herein defined are disclosed as useful in a method for modulating the androgen receptor in a tissue selective manner in a patient in need of such modulation,...
7345082 Phosphinic acids  
The present invention relates to phosphinic acid derivatives of formula I wherein R 1 , R 2 , R 3 and R 4 are described hereinabove. These compounds can be used in the treatment or prevention...
7345032 Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]ethyl}phosphonic acid and esters thereof  
The present invention provides methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl]et hyl}phosphonic acid, and esters thereof.
7300924 Anti-infective phosphonate analogs  
The invention is related to phosphorus substituted anti-infective compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as...
7282514 Reactive probes for two-photon fluorescent imaging and sensing  
Fluorescent dyes and probes are key components in multiphoton based fluorescence microscopy imaging of biological samples. In order to address the demand for better performing dyes for two-photon...
7268123 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them  
Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided: wherein: A is alkylenyl of 1 to 4 carbon atoms, or alkenylenyl of 2 to 4 carbon atoms; R 1 and R 2 ...
7253153 Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl] phosphonic acid and methods of use thereof  
Compounds of formula (I) or pharmaceutically acceptable salts thereof are provided where at least one of R 2 or R 3 is not hydrogen. The compounds of the present invention are...
7247610 Use of glutamate antagonists for the treatment of cancer  
Disclosed are methods for treating cancer by administering an inhibitor of the interaction of glutamate with the KA receptor complex.
7235537 N3 alkylated benzimidazole derivatives as MEK inhibitors  
Disclosed are compounds of the formula I and pharmaceutically acceptable salts and prodrugs thereof, wherein W, R 1 , R 2 , R 7 , R 8 , R 9 and R 10 are as defined in the specification. Such...
7226915 Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors  
This invention relates to diaminopyrroloquinazoline compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose...
7214701 Active substance combinations having insecticidal and acaricdal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G...
7202234 Compounds and methods for treating Toll-like receptor 2-related diseases and conditions  
The present invention relates to compounds and methods useful in the prevention or treatment of diseases or conditions associated with Toll-like receptor 2 activation.
7176196 Bicyclic heterocycles as HIV integrase inhibitors  
The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds...
7157447 Bicyclic heterocycles as HIV integrase inhibitors  
The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for...
7138388 Methods to treat autoimmune and inflammatory conditions  
This invention provides methods for treating inflammatory or autoimmune diseases by contacting the affected cell or tissue with a therapeutic compound as described herein. Such pathologies include,...
7132427 Quinazolines and uses thereof  
This invention relates to compounds of the general formula: in which R A , R B , R C and R D are as defined herein, and to their preparation and use.
7129225 Protection against and treatment of hearing loss  
The present invention provides a method for protecting against or treating hearing loss in a subject. This method involves administering an effective amount of a protein tyrosine kinase inhibitor...
7098196 Regulators of the hedgehog pathway, compositions and uses related thereto  
The present invention makes available, inter alia, methods and reagents for modulating smoothened-dependent pathway activation. In certain embodiments, the subject methods can be used to counteract...
7041658 Method of inhibiting hair growth  
Disclosed herein are a method of inhibiting hair growth, which comprises administering an inhibitor of elastase-like enzymes or a neutral endopeptidase inhibitor, and use of an inhibitor of...
7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors  
The present invention is related to new substituted pyrrolidine derivatives of formula (I). Said compounds are preferably for use as pharmaceutically active compounds. Specifically, pyrrolidine...
6987100 Pharmaceutical compositions for treating bone lesions in multiple myeloma  
Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both...
6930101 Thiazolopyrimidines useful as TNFα inhibitors  
The invention provides derivatives of thiazolo[4,5-dl]pyrimidine and their use as inhibitors of proinflammatory cytokines.
6930100 Phosphate prodrugs of fluoroxindoles  
The present invention provides novel phosphate derivatives having the general Formula I wherein the wavy bond ( ) represents the racemate, the (R)-enantiomer or the (S)-enantiomer and A, B, R...
6908908 Biologically active 4H-benzo [1,4] oxazin-3-ones  
The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. Pharmaceutical compositions comprising compounds...
6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors  
The present invention provides novel compounds of the Formula (I): A-B, its prodrug forms, or pharmaceutically acceptable salts thereof, wherein A represents a saturated, unsaturated, or a...
6864276 Active substance combinations having insecticidal and acaricidal properties  
The invention relates to insecticidal mixtures for protecting plants against attack by pests comprising (a) compounds of the formula (I) in which W, X, Y, Z, A, B, D and G are each as...
6841559 Pyridinones to treat and prevent bacterial infections  
Novel pyridinones and their derivatives which are effective in treating or preventing Gram-negative bacterial infections are provided. The pyridinones are stable and easily derivatized; the methods...
6825211 Bicyclic metabotropic glutamate receptor ligands  
The present invention provides bicyclic metabotropic glutamate receptor ligands, as well as compositions comprising such ligands, and methods for their use.
6797692 Use of glutamate antagonists for the treatment of cancer  
Glutamate antagonists (NMDA, AMPA and kainate receptor antagonists) and their physiologically compatible salts can be used for the preparation of drugs for treatment of cancer.
6794371 Aminoalkylenephosphonates for treatment of bone disorders  
A method for preventing loss of bone mineral in mammals which method comprises administering to a mammal an amount of an aminoalkylenephosphonate which is effective to prevent or minimize loss of...
6777445 Fullerene pharmaceutical compositions for preventing or treating disorders  
The present invention relates to a method for treating a disease, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a fullerene. The diseases...
6727233 Medicinal compositions for treating osseous lesion in multiple myeloma  
Pharmaceutical compositions for treating bone lesions in multiple myeloma or pharmaceutical compositions for treating multiple myeloma which contain as an active ingredient a compound having both...
6716828 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage  
This invention relates to compounds, pharmaceutical compositions, and methods for the treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion...
6706698 α-Substituted β-aminoethyl phosphonate derivatives  
The present invention relates to novel α-substituted-β-aminoethylphosphonate and α-substituted-β-aminovinylphosphonate derivatives and their uses for lowering plasma levels of apo (a), Lp(a),...
6699896 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia  
This invention provides compounds having the structure wherein A is OR 5 , or R 1 is alkyl, cycloalkyl of 3-8 carbon atoms, thienyl, furyl, pyridyl, R 2 is H, alkyl, or aryl; R 3 and R 4 ...
6699855 Inhibitors of hepatitis C virus NS3 protease  
The present invention relates to compounds of Formula (I): wherein A 1 is methylene, ethylene or propylene group and A 2 is N or CR 5 , or stereoisomeric forms, stereoisomeric mixtures, or...
6683082 Bicyclic protein kinase inhibitors  
The present invention relates to novel 3-hetero-arylidene-2-indolinone compounds and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are...
6673781 Tricyclic compounds having sPLA2-inhibitory activities  
The present invention provides a compound having sPLA 2 inhibiting activity. The compound represented by the formula (I): wherein R 1 is (a) C1 to C20 alkyl, C2 to C20 alkenyl, C2 to C20...
6673780 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses  
The present invention relates to novel sulfoxide and bis-sulfoxide compounds, compositions comprising sulfoxide and bis-sulfoxide compounds, and methods useful for treating and preventing...
6656926 Phosphoramide compounds  
The invention provides a compound of formula I: wherein R 1 , R a , R b , R c , and R d have any of the values defined in the specification, as well as pharmaceutical compositions comprising...
6645950 Benzimidazole vascular damaging agents  
Vascular damaging agents composed of substituted 5(6)-substituted benzimidazole-2-carbamates are provided. These agents are useful in the preparation of medicaments for the treatment of diseases...
6638960 Halogenobenzimidazoles and their use as microbicides  
New halogenobenzimidazoles of the formula in which A, R 1 , R 2 , R 3 , R 4 and X have the meanings given in the description, and their acid addition salts and metal salt complexes, a process...
6635626 Imidazoquinoxaline protein tyrosine kinase inhibitors  
Novel imidazoquinoxalines and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated...
6596709 6-sulphanoyl-3-quinolylphosphonic acid compounds  
The invention relates to a compound of formula (I): wherein: X represents chlorine or fluorine or CF 3 , R represents hydrogen or a group and methods for using the same.
6555536 Biologically active 4H-benzo &lsqb 1,4&rsqb oxazin-3-ones  
The invention is directed to 4h-benzo[1,4]oxazin-3-ones useful as peroxisome proliferator activated receptor gamma (PPARγ) agonists or antagonists. Pharmaceutical compositions comprising compounds...
6555528 Derivatized biotin compounds and methods of use  
An efficient synthesis for the selective and efficient 1′-N derivatization of biotin is reported. The derivatized biotin acts as a stable analog of the carboxyphosphate intermediate in...